AzTrials
AzTrials

Circadian RhythmNCT03934255

Circadian Mechanisms Underlying Non-Dipping Blood Pressure in Blacks

A study testing Constant Routine Protocol in people with Circadian Rhythm and Blood Pressure, run by University of Alabama at Birmingham at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study seeks to examine central and peripheral circadian mechanisms in Blacks with appropriately dipping systolic blood pressure (blood pressure that dips by at least 10%) compared with non-dipping systolic blood pressure (blood pressure that dips by less than 10%) using a constant routine protocol. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Circadian Rhythm, Blood Pressure
What is being tested?
Constant Routine Protocol
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 siteUnited States
Study dates
1 Jan 2020to 1 May 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Black or African American race
  • Age 18 years or older

Who cannot join

  • Work alternating or night shifts
  • Pregnant or nursing
  • Current illicit drug use
  • History of severe mental illness
  • Medical conditions that would be contraindicated for a constant routine protocol
  • Take anti-hypertensive medications or beta-blockers
  • Severe obstructive sleep apnea

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Alabama at Birmingham

    Birmingham, Alabama, 35294-0017

Other trials in United States

About this study

Official title: Central and Peripheral Circadian Mechanisms Underlying Non-Dipping Blood Pressure in Blacks

This study seeks to examine central and peripheral circadian mechanisms in Blacks with appropriately dipping systolic blood pressure (blood pressure that dips by at least 10%) compared with non-dipping systolic blood pressure (blood pressure that dips by less than 10%) using a constant routine protocol. Constant routine protocols are commonly used in the field of circadian biology to examine rhythms in biological processes while controlling the entraining effects of light, activity, and diet.

Read the detailed description

This study will enroll a total of 40 participants (n=20 non-dippers; n=20 dippers) to complete a 30-hour constant routine protocol. Participants will undergo baseline testing that includes anthropometric measurements, clinic blood pressure measurements, completion of self-report questionnaires on sleep and mood, be fitted with an ambulatory blood pressure monitor and actigraphy watch, and be provided with home sleep testing (HST) equipment.

Following completion of baseline assessment, eligible participants will be scheduled for the 30-hour constant routine protocol. The 30-hour constant routine protocol will allow for the hourly collection of saliva, collection of buccal cells every 4 hours, and constant monitoring of core body temperature, all of which are primary outcomes in the assessment of central and peripheral circadian clock markers. Amplitude and phase of these outcomes will be assessed in non-dippers versus dippers.

Being tested
Constant Routine Protocol

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Constant Routine ProtocolOther

    Constant routine protocols are used in circadian research to examine underlying circadian rhythms in the absence of light, activity, and meals

Study groups in NCT03934255
Study groupRoleWhat they receive
Constant Routine ProtocolExperimentalParticipants will be kept in constant conditions for 30 hours to observe circadian physiology in the absence of light, physical activity, and meals.
Receives: Other: Constant Routine Protocol

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Melatonin phase

    Circadian phase of melatonin obtained from saliva

    Measured: Melatonin phase during a 30-hour constant routine protocol

  2. Melatonin amplitude

    Circadian amplitude of melatonin obtained from saliva

    Measured: Melatonin amplitude during a 30-hour constant routine protocol

  3. Core body temperature phase

    Circadian phase of core body temperature recorded and transmitted wirelessly

    Measured: Core body temperature phase during a 30-hour constant routine protocol

  4. Core body temperature amplitude

    Circadian amplitude of core body temperature recorded and transmitted wirelessly

    Measured: Core body temperature amplitude during a 30-hour constant routine protocol

  5. Buccal cell mRNA expression

    Expression of Bmal1 and Period 3 obtained from buccal cell mRNA

    Measured: Expression of Bmal1 and Period 3 during a 30-hour constant routine protocol

Secondary outcomes (2)
  1. Cortisol phase

    Circadian phase of cortisol obtained rom saliva

    Measured: Cortisol phase during a 30-hour constant routine protocol

  2. Cortisol amplitude

    Circadian amplitude of cortisol obtained rom saliva

    Measured: Cortisol amplitude during a 30-hour constant routine protocol

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 May 2019
  2. Study start1 Jan 2020
  3. Primary completion1 May 2023
  4. Study completion1 May 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Model description
Constant routine protocol in Blacks with dipping and non-dipping blood pressure
Masking
None (open label)
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03934255
Sponsor's protocol ID
IRB-300003266
Status last verified
Jun 2023
First submitted
19 Apr 2019
Last updated
8 Jun 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Details regarding sharing IPD are undecided. Protocols and consent forms will be shared. Requests may be made to the study PI.

Questions about this trial

What is this clinical trial studying?

A study testing Constant Routine Protocol in people with Circadian Rhythm and Blood Pressure, run by University of Alabama at Birmingham at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Melatonin phase (time frame: Melatonin phase during a 30-hour constant routine protocol). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jun 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in